Biomarker-based diagnosis of preclinical Alzheimer disease: time for the clinic?

Nat Rev Neurol. 2023 Feb;19(2):71-72. doi: 10.1038/s41582-022-00767-x.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Alzheimer Disease* / diagnosis
  • Amyloid beta-Peptides
  • Biomarkers
  • Humans

Substances

  • Amyloid beta-Peptides
  • Biomarkers